BNP Paribas Financial Markets’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$57 Hold
2
﹤0.01% 5823
2026
Q1
$63 Sell
2
-100,000
-100% -$3.15M ﹤0.01% 5712
2025
Q4
$2.95M Sell
100,002
-150,000
-60% -$4.17M ﹤0.01% 2383
2025
Q3
$6.31M Buy
250,002
+250,000
+12,500,000% +$6.09M ﹤0.01% 1835
2025
Q2
$48 Sell
2
-225,000
-100% -$5.22M ﹤0.01% 5359
2025
Q1
$5.15M Hold
225,002
﹤0.01% 1793
2024
Q4
$5.7M Buy
+225,002
New +$5.7M ﹤0.01% 1698

Other funds holding RTO

BNP Paribas Financial Markets's RTO Position: Q2 2026 in Review

BNP Paribas Financial Markets held its Rentokil (RTO) position steady in Q2 2026 at 2 shares worth $57. The position accounts for ﹤0.01% of the portfolio, ranked #5823.

BNP Paribas Financial Markets first reported a position in RTO in Q4 2024 and has held it in 7 quarters since. The position peaked at $6.31M in Q3 2025. 274 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • BNP Paribas Financial Markets held 2 shares of Rentokil worth $57 as of Q2 2026.
  • BNP Paribas Financial Markets left its Rentokil share count unchanged in Q2 2026.
  • Rentokil made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5823 holding.
  • BNP Paribas Financial Markets first reported a position in Rentokil in Q4 2024 and has held it in 7 quarters since.
  • BNP Paribas Financial Markets's Rentokil position peaked at $6.31M in Q3 2025.
  • 274 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.